A consensus statement on the use of biosimilar medicines in hematology in Australia.

Gregory, Gareth P; Carrington, Christine; Cheah, Chan Y; Hawkes, Eliza A; Irving, Ian M; Siderov, Jim; Opat, Stephen

Gregory, Gareth P; Carrington, Christine; Cheah, Chan Y; Hawkes, Eliza A; Irving, Ian M; Siderov, Jim; Opat, Stephen.

Afiliación

Gregory GP; Monash Haematology, Monash Health, Clayton, Victoria, Australia.
Carrington C; School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Cheah CY; Department of Pharmacy, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Hawkes EA; School of Pharmacy, University of Queensland, Brisbane, Queensland, Australia.
Irving IM; Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine WA, Nedlands, Western Australia, Australia.
Siderov J; Medical School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.
Opat S; Olivia Newton-John Cancer Research & Wellness Centre, Austin Health, Melbourne, Victoria, Australia.

Asia Pac J Clin Oncol ; 16(4): 211-221, 2020 Aug.

Article en En | MEDLINE | ID: mdl-32285612

Asunto(s)

Biosimilares Farmacéuticos/uso terapéutico; Hematología/métodos; Australia; Biosimilares Farmacéuticos/farmacología; Humanos

Palabras clave

biosimilars; consensus statement; hematology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Hematología Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Asia Pac J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google